Abstract:The current coronavirus disease 2019 (COVID-19) pneumonia pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading globally at an accelerated rate, with a basic reproduction number (R0) of 2-2.5, indicating that 2-3 persons will be infected from an index patient. A serious public health emergency, it is particularly deadly in vulnerable populations and communities in which healthcare providers are insufficiently prepared to manage the infection. As of March 16, 2020, there are more than 180,000 confirmed cases of COVID-19 worldwide, with more than 7000 related deaths. The SARS-CoV-2 virus has been isolated from asymptomatic individuals, and affected patients continue to be infectious 2 weeks after cessation of symptoms. The substantial morbidity and socioeconomic impact have necessitated drastic measures across all continents, including nationwide lockdowns and border closures. Pregnant women and their fetuses represent a high-risk population during infectious disease outbreaks. To date, the outcomes of 55 pregnant women infected with COVID-19 and 46 neonates have been reported in the literature, with no definite evidence of vertical transmission. Physiological and mechanical changes in pregnancy increase susceptibility to infections in general, particularly when the cardiorespiratory system is affected, and encourage rapid progression to respiratory failure in the gravida. Furthermore, the pregnancy bias toward T-helper 2 (Th2) system dominance, which protects the fetus, leaves the mother vulnerable to viral infections, which are more effectively contained by the Th1 system. These unique challenges mandate an integrated approach to pregnancies affected by SARS-CoV-2. Here we present a review of COVID-19 in pregnancy, bringing together the various factors integral to the understanding of pathophysiology and susceptibility, diagnostic challenges with real-time reverse transcription polymerase chain reaction (RT-PCR) assays, therapeutic controversies, intrauterine transmission, and maternal-fetal complications. We discuss the latest options in antiviral therapy and vaccine development, including the novel use of chloroquine in the management of COVID-19. Fetal surveillance, in view of the predisposition to growth restriction and special considerations during labor and delivery, is addressed. In addition, we focus on keeping frontline obstetric care providers safe while continuing to provide essential services. Our clinical service model is built around the principles of workplace segregation, responsible social distancing, containment of cross-infection to healthcare providers, judicious use of personal protective equipment, and telemedicine. Our aim is to share a framework that can be adopted by tertiary maternity units managing pregnant women in the flux of a pandemic while maintaining the safety of the patient and healthcare provider at its core.

[The value of electrophoretic studies of urinary proteins in clinical practice].

Pregnancy with COVID-19: Management considerations for care of severe and critically ill cases

COVID-19 in the Critically Ill Pregnant Patient

A Comprehensive Review of the Management of Pregnant Women with COVID-19: Useful Information for Obstetricians

Obstetric Management of COVID-19 in Pregnant Women

Test Tube Tooth: The Next Big Thing.

Safe Delivery for Pregnancies Affected by COVID‐19

Surgical Strategies: Mau Osteotomy for Correction of Moderate and Severe Hallux Valgus Deformity

COVID-19 complicating pregnancy: A retrospective study of nine intensive care unit patients

Living Diabetes: How Disease Perceptions and Cultural Factors Influence Self-Care Behaviors in South Asians in America

Clinical Characteristics and Neonatal Outcomes of Pregnant Patients With COVID-19: A Systematic Review

QSAR studies on human 5alpha-reductase inhibitors: unsaturated 3-carboxysteroids.

Coronavirus disease 2019 (COVID-19) pandemic and pregnancy

[Pregnant Women Complicated with COVID-19: a Clinical Analysis of 3 Cases].

Management of Pregnancy during the COVID-19 Pandemic.

Management of a delivery suite during the COVID-19 epidemic

Management and Prevention of COVID-19 in Pregnancy and Pandemic Obstetric Care: A Review of Current Practices

Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review

Expert Consensus for Managing Pregnant Women and Neonates Born to Mothers with Suspected or Confirmed Novel Coronavirus (COVID‐19) Infection

[Incidence and etiology of Down's syndrome].

Analysis of the Susceptibility to COVID-19 in Pregnancy and Recommendations on Potential Drug Screening.